Daily Brief Archive: July 14, 2026 — U.S. & Hong Kong Stock Analysis

Free preview

U.S. Markets

  • SK Hynix cratered 15.4% — its worst day ever — dragging the SOX down; SOXL fell 14% in one session
  • KOSPI plunged 9.95%, tripping its 7th circuit breaker this year; Samsung -10.7%, index now 27% off the June peak
  • US-Iran strikes escalated: Tehran declared Hormuz 'unnavigable'; Brent jumped 5% through $80
  • Energy bucked the tape: XLE +3%, XOP +4.2%; richly valued software dumped — AppLovin's 5-day slide hit -18.6%
  • Oracle fell 6.5% for a ninth straight loss and a fresh 52-week low — no antidote yet for the capex-and-debt narrative
  • Microsoft +1.5% and IBM +0.9%: defensive money hid in big-cap value tech

Hong Kong

  • Hang Seng opened soft this morning; tech lagged — Baidu fell as much as 8% to lead decliners, Zhipu -10%
  • Kunlunxin's IPO 'bundling' clause stirred controversy; the market voted with its feet on Baidu's spin-off premium
  • Oil & petrochemicals outperformed: Sinopec +2.4%; Zijin +3.3% as gold-copper repair continued
  • CXO names hit highs against the tape: Asymchem +4.9% near a record, WuXi Bio printed another swing high
  • GigaDevice V-bounced 9.5% the day after its lock-up expiry; MiniMax caught a 3.3% oversold breather
  • Lithium bounced from oversold: Ganfeng +2.8%, Tianqi +3.3% — the weekly wounds are far from healed

Today's Watchlist

  • Tonight 8:30pm HKT: US June CPI — consensus sees 4.2%→3.9%, core 2.9%; the year's biggest data point
  • All five megabanks report premarket tonight; the SpaceX IPO lifts group IB revenue estimates by 26%
  • New Fed Chair Warsh gives his first Congressional testimony; markets are pricing rising odds of a September hike
  • Hormuz: US floats a maritime blockade plus a 20% transit levy — oil risks a second spike
  • Position tripwires: TSLA $390, NVDA $196, BEAM $30.5, CELH $29.6
  • Ahead: TSLA and IBM report 7/22; SpaceX's first earnings and first lock-up expiry land 8/6

Deep Dives (1 names)

Neutral
Score6/105-day slide -18.6% (~$34B market cap erased)Company news No 8-K, no downgrade, no guidance cutRSI(7) 28.0Rel. volume 2.07xConsensus target $667 (+50%)

TechnicalsBroken below every moving average (20-day $499, 50-day $507, 200-day $536). The $440 level — April's platform rim — is the last technical defense. Volume ran 2.07x on the plunge and RSI at 38 isn't even oversold yet; don't rush to call bottoms.

FundamentalsQ1 EPS of $3.56 on $1.84B revenue (+24%) — the AXON ad engine's profit machine isn't broken. This is a valuation purge, not an earnings problem; but BofA's third-party tracking flagged slower June e-commerce ad growth, which pokes precisely at the most expensively priced part of the story.

NewsMonday's 12.65% drop came with zero company-specific catalyst — pure AI/software risk-off front-running; the five-day slide totals 18.6%. BofA calls the selloff 'overdone,' but money is clearly selling first and asking later.

Short-term · 1–3 weeks
Neutral Sidelines

A decline without a reason is the hardest to trade — there's no way to know which day the selling exhausts. With volume still heavy and every average broken, the only correct move is waiting.

Entry Long talk resumes only if $440 holds on shrinking volume and the $470 gap gets reclaimed; below $430 the $400 round number is nextStop Target
Long-term · months+
Neutral

AXON's profitability is real and rare, and this pullback is dragging the valuation back toward reasonable; but the AI-ad lane is getting crowded and platform pressure from Meta/Google is rising.

  • E-commerce ad demand rolling over
  • Algorithm/traffic squeeze by platform giants
  • Volatile holder base dominated by momentum money
Institutional Views
  • 华尔街共识 · 37 analysts average $667 — 50% above spot; 1.15 rating
  • BofA / Investing.com · June e-commerce ad growth slowed, but the current selloff is viewed as overdoneSource ↗
  • Trefis · Five straight red days, down 19% — a textbook momentum-money retreatSource ↗

Rapid Scan (13 names)

TickerCloseChangeScoreDirectionOne-line take
NU logoNUUS$13.67-0.65%5NeutralDown 0.7% to $13.67 — a hot-list regular with no fresh catalyst; sidelines
WBD logoWBDUS$27.09+1.88%6NeutralUp 1.9% to $27.09 on 3x volume — hot money chasing break-up chatter; watch the show, skip the stage
HCA logoHCAUS$390.74-3.90%5NeutralDown 3.9% to $390.74 as hospitals bled together (THC -4.6%); wait for the sector cloud to clear
LOW logoLOWUS$207.7-1.86%5NeutralDown 1.9% to $207.70, -8.9% on the week — home improvement keeps cooling under high rates; sidelines
AZN logoAZNUS$169.47-1.25%5NeutralDown 1.3% to $169.47 after a 10.9% weekly slide — no basing structure yet in this pharma pullback; sidelines
ALNY logoALNYUS$288.06-3.58%5NeutralDown 3.6% to $288.06 as the RNAi leader gives back with biotech — 42% off the high but the knife's still falling; sidelines
KVUE logoKVUEUS$19.23-1.28%5NeutralDown 1.3% to $19.23 with the consensus target a whisker away (+0.9%) — even defense has to price right; sidelines
CCJ logoCCJUS$90.2-6.03%6NeutralDown 6.0% to $90.20 with dual-channel resonance — uranium's AI-nuclear story is buying tickets for round two on this dip; RSI 31 puts it on watch, wait for the base
TEAM logoTEAMUS$96.16+8.22%6NeutralUp 8.2% to $96.16 — dead-cat bounce or turning point 53% off the high? One green candle doesn't answer that; sidelines
KNX logoKNXUS$74.33-1.14%5NeutralDown 1.1% to $74.33 — the freight-cycle name drifts with the tape, no catalyst of its own; sidelines
BIIB logoBIIBUS$209.03+4.96%6NeutralUp 5.0% to $209.03 on 1.6x volume, leading pharma on a red day — looks right-side, but with the catalyst unclear, sidelines
CPNG logoCPNGUS$17.92-4.68%5NeutralDown 4.7% to $17.92, guilty by KOSPI association — Korean exposure was today's original sin; sidelines
EXPD logoEXPDUS$175.5+2.02%6NeutralUp 2.0% to $175.50, dual-channel at the 52-week high — but consensus targets sit 12% below; a crowded safety trade isn't worth chasing
Stock Brief 2026-07-14: Daily U.S. & HK Market Analysis Archive · Quant Brief